Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > Blood-Brain Barrier (BBB) Market Overview
View:
Post by chrispi on Feb 01, 2022 7:31am

Blood-Brain Barrier (BBB) Market Overview

Blood-Brain Barrier (BBB) Market Overview, Merger and Acquisitions , Drivers, Restraints and Industry Forecast By 2028

Emergen Research

Major prevalence of neurological disorders and rapidly increasing geriatric population are key factors driving growth of the global blood-brain barrier market

SURREY, BRITISH COLUMBIA, BRITISH COLUMBIA, January 20, 2022 /EINPresswire.com/ -- The global blood-brain barrier (BBB) market size is expected to reach USD 7.40 Billion in 2028 at a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Major factors driving market revenue growth include major prevalence of neurological disorders such as Parkinson’s Disease, Alzheimer’s Disease, Hunter’s Syndrome, and brain tumors. Other factors include rising healthcare expenses and increasing investment in pharmaceutical research and development. Blood-brain barrier plays a vital role in protecting the brain from toxic compounds and many blood-borne disorders. It helps to prevent the circulation of compounds from the circulatory systems to Cerebrospinal Fluid (CSF) or brain through a particular exchange of components controlled by BBB or blood CSF barrier. This function also significantly impedes delivery of drugs to the brain. In case of central nervous system disorders, it is required to deliver drugs across this barrier and provide the appropriate therapeutic effect to the targeted location.

The Global Blood-Brain Barrier (BBB) Market Research Report published by emergen research has been formulated by analysis of key business details and extensive geographical spread of the Blood-Brain Barrier (BBB) industry. The study offers comprehensive coverage of the qualitative and quantitative analysis of the Blood-Brain Barrier (BBB) market along with crucial statistical data about the Blood-Brain Barrier (BBB) market. The research study provides historical data from 2017 to 2018 and offers accurate forecast estimation until 2027. The report also profiles established and emerging players of the market, covering the business overview, product portfolio, strategic alliances, and business expansion strategies.

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/633

Key players operating in the market are Allon Therapeutics, Inc., Angiochem Inc., Armagen Technologies, Inc., Bristol-Myers Squibb, BiOasis Technologies, Inc., Sanofi Genzyme, CarThera, Cephalon Inc., Nanomerics, and F. Hoffman La-Roche AG.

In January 2021, Nanoform Finland signed an agreement with Herantis Pharma. This agreement will help both companies to improve blood-brain-barrier penetration in nasal drug delivery routes for Parkinson’s therapies using nanoparticle technology.

Parkinson’s disease segment accounted for major revenue share in global market in 2020 and is expected to register a 25.1% CAGR throughout the forecast period. This is attributed to major prevalence of Parkinson’s Disease among an expanding global patient pool.

Market Dynamics:

The report offers insightful information about the market dynamics of the Blood-Brain Barrier (BBB) market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Blood-Brain Barrier (BBB) market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the Blood-Brain Barrier (BBB) market.

For the purpose of this report, Emergen Research has segmented the global blood-brain barrier (BBB) market based on application, technology, end-use, and by region:

Application Outlook (Revenue, USD Billion; 2018–2028)

Alzheimer’s Disease

Epilepsy

Parkinson’s Disease

Multiple Sclerosis

Hunter’s Syndrome

Brain Cancer

Technology Outlook (Revenue, USD Billion; 2018–2028)

Bispecific Antibody RMT Approach

Trojan Horse Approach

Increasing Permeability

Passive Diffusion

Others

End-Use Outlook (Revenue, USD Billion; 2018–2028)

Hospitals

Surgical centers

Research Institutes

Others

The current COVID-19 pandemic is expected to have an effect on the growth of the Blood-Brain Barrier (BBB) industry majorly attributable to the movement restrictions and impact on the supply and demand due to the lockdowns. The COVID-19 pandemic has affected several sectors of the global market, and the Blood-Brain Barrier (BBB) sector is expected to feel the impact of the pandemic. The economic slowdown and dynamic changes in the demands will further affect the growth of the industry. The report covers the impact analysis of the COVID-19 pandemic on the overall Blood-Brain Barrier (BBB) industry.

The report further studies the latest technological and product developments of the regions and offers key insights into current and emerging trends. It also studies investment opportunities, consumption and production patterns, supply and demand, consumer demand and behavior, economic growth, macro- and micro-economic growth factors, regulatory framework, government support, and presence of key players in each region. The key regions list comprises of North America, Latin America, Europe, Asia Pacific, and Middle East & Africa along with their market size, market share, and revenue CAGR with key factors influencing the market growth.

Request customization of the report: https://www.emergenresearch.com/request-for-customization/633

Key questions addressed in the report:

Who are the leading players dominating the global Blood-Brain Barrier (BBB) Market?

Which factors could potentially hamper the global market growth during the forecast period?

Which regional market offers the most attractive growth opportunities to the companies operating in this market?

How is the raw material availability affecting the demand for Blood-Brain Barrier (BBB) in this industry vertical?

The study dives deep into the profiles of top market players and their key financials. This comprehensive report is not only for business analysts and any existing and new entrant can use it when designing their business strategies. The research is one of its kind global analyses of aspects such as import and export status, supply chain management, profit and gross margin worldwide for the forecast period 2020 - 2027. Extensive coverage of statistics associated with recent events including acquisition and mergers and strengths and weaknesses of a company forms an important part of the study on the Blood-Brain Barrier (BBB) market.
Table of Content

Chapter 1. Blood-Brain Barrier (BBB) Market Methodology & Sources

1.1. Blood-Brain Barrier (BBB) Market Definition

1.2. Blood-Brain Barrier (BBB) Market Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2018-2028

Chapter 3. Key Insights

Chapter 4. Blood-Brain Barrier (BBB) Market Segmentation & Impact Analysis

4.1. Blood-Brain Barrier (BBB) Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Blood-Brain Barrier (BBB) Market indicators analysis

4.2.2. Blood-Brain Barrier (BBB) Market drivers analysis

4.2.2.1. Increasing energy consumption and prices

4.2.2.2. Rising government policies regarding energy efficiency

4.2.2.3. Increasing smart grid services

4.2.3. Blood-Brain Barrier (BBB) Market restraints analysis

4.2.3.1. Highly competitive with presences of local & global players

4.2.3.2. Present challenging economic conditions due to the pandemic

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Chapter 5. Blood-Brain Barrier (BBB) Market By Form Factor Insights & Trends, Revenue (USD Billion)

Chapter 6. Blood-Brain Barrier (BBB) Market By Input type Insights & Trends Revenue (USD Billion)

Chapter 7. Blood-Brain Barrier (BBB) Market By Application Insights & Trends, Revenue (USD Billion)

Chapter 8. Blood-Brain Barrier (BBB) Market By End-use Insights & Trends, Revenue (USD Billion)

Chapter 9. Blood-Brain Barrier (BBB) Market Regional Outlook

Continued…

Read More: https://www.emergenresearch.com/industry-report/blood-brain-barrier-market

Comment by JDavenport on Feb 01, 2022 10:40am
These BBB "reports" are kind of funny. They and others like this one have been around for years. Usually, the same report was offered under several brand names, all costing from US$5000.00 and higher. They were, and likely remain, copies of the same report published from year to year with  minor changes like new dates and CAGR calculations inserted for successive years.  ...more  
Comment by chrispi on Feb 01, 2022 12:37pm
Here’s one from 2020 that I found to be the most comprehensive (at least in terms of indexes) https://www.researchandmarkets.com/reports/5025060/blood-brain-barrier-bbb-market-2nd-edition#src-pos-3 I only posted the report so people can peruse the chapter index.
Comment by beenthere on Feb 01, 2022 6:13pm
Chrispi the Believer! I ( we) here by appoint you the Master and Caretaker of the BTI BullBoard! We thank JD for his many years of faithful service! We wish  him well in his retirement!
Comment by JDavenport on Feb 01, 2022 6:29pm
Well, beenthere, one thing about chrispi, his copy/pasting will be exclusively to the upside. No flipping like prophetofobviousfacts does. There's going to be lots more stuff from me, too. I have a long list of posts and years of motive. And there will be the required responses every time may name is mentioned. That's carved in stone. jd
Comment by beenthere on Feb 01, 2022 8:04pm
JD I am sorry!  I guess I misunderstood your posts from the past week! I thought you were done with BTI  and this bullboard and moving on to greater things! I have no problem! Actually I am not the least bit surprised. I have lost track to be honest but in the past there have been many times  you indicated you were done but always came back. Because you seemed so ...more  
Comment by JDavenport on Feb 01, 2022 8:15pm
Well, beenthere, why TF are you surprised? You admitted that you don't read my posts. Of course you don't know what I said. Duh! Never enter a war of wits unarmed. jd
Comment by beenthere on Feb 01, 2022 8:51pm
I was talking those long long rambling posts! It was your shorter ranting ones I did read! lol
Comment by JDavenport on Feb 01, 2022 9:11pm
I know what you're saying, beenthere. I said goodbye twice in the last few days, I think, but the attacks continued. Whether it's Bioasis not paying me or people on here attacking me, I need everybody to understand that I will not back down. For ten years I have tried to help people understand xB3 and the opportunities and challenges that Bioasis might have. I will have something to say ...more  
Comment by beenthere on Feb 01, 2022 9:38pm
Continue! You may see it as you are being attacked but maybe that's not the case. BTI is being attacked and as the messenger of BTI you are being attacked for defending them! Don't take it so personal! Life is too short and we may not have much of it left!
Comment by JDavenport on Feb 01, 2022 9:52pm
Yeah, right, you dish it out, claim, "no offense, nothing personal," and then you're the victim. I get it.
Comment by beenthere on Feb 02, 2022 12:44pm
You seemed a little down. Just trying to help! And Yes of course I'm a victim! Aren't we all? Well some more than others! We all have been taken down the road with BTI Management incompetence and have lost our investment! And others lost their investment capital and their pay cheque as well!
Comment by Finallytherock on Feb 04, 2022 2:13pm
There is nothing going on here. Another year of no progress. Anything from Chiasi? Nope. Jd, Stop acting like something big is going on behand closed doors. You have been doing this for years. There is nothing going on. NOTHING
Comment by chrispi on Feb 04, 2022 3:19pm
There is lots going on here. There is lots going on. LOTS You'll see :)
Comment by JDavenport on Feb 04, 2022 3:35pm
chrispi, stop. You have no idea about deal timing. Your "research" is sounding like that done by unvaccinated football players.  Let's make an assumption. There will be a deal at some point. So if you keep saying three times a week that a deal is imminent, then when a deal happens you will be off by, at most, 4 days with your latest prediction. Then you can shout, "I told ...more  
Comment by Georgeparros on Feb 04, 2022 3:47pm
Even me, who's a diehard Bioasis fanboi, thinks these messages are not giving credibility to you or the company. It's been years since you started saying this. Plus, it implies you know material information we dont. Finally, if I knew deals were coming, it shut the hell up and I'd scoop these quarter dollar shares.
Comment by chrispi on Feb 04, 2022 4:06pm
my humorous post was strictly a comeback to the m*r*nic post by Finallytherock who posted that nothing is happening as I can guarantee you they are posting that without any evidence, just as my reply is based on no evidence. I get the frustration by shareholders ... I really do but to say there is nothing going on is falso and ridiculous.
Comment by fuzzyjr on Feb 04, 2022 4:19pm
" I can guarantee you they are posting that without any evidence, just as my reply is based on no evidence" been your case for years now along with your deputy jd. maybe zip it 4 bit ,u can flap your gums when or if the day comes.Right now u & your posse look & sound like fools. not saying there's nothing here but you've made it more than obvious that you ...more  
Comment by JDavenport on Feb 04, 2022 4:47pm
Fuzz off, Bucky Jr. You're no different than the rest of us. Caught at 24¢. For now... chrispi, I apologize for the snark. I didn't realize you were kidding. Nevertheless, the snark was fun to write.  jd
Comment by Finallytherock on Feb 05, 2022 10:21am
He wasn't kidding. He's ashamed that you attacked him so he is trying to save face. Everyone here, including you,  knows he's worthless.
Comment by Georgeparros on Feb 04, 2022 4:21pm
I agree Chrispi, I prefer your message and your tone than his. However, both are useless here.
Comment by Finallytherock on Feb 05, 2022 10:20am
No it wasn't, Chrispi. You're just trying to pretend it was but everyone on this board knows you are a joke. Even longs are laughing at you  and disregarding what you have to say
Comment by chrispi on Feb 05, 2022 10:34am
I'm so glad you had the time to contact everyone on this board and get their opinion. Perhaps you could have taken a tally of the shares they own and then we could compare that total to my holdings. Signed "the jokester" P.S. I wasn't going to reply to your post but I can tell you're fuming at the keyboard when you read my posts so how could I let that opportunity to incense ...more  
Comment by craighenry on Feb 05, 2022 2:15pm
chrispi the clown. Man, I have never in my life came across such a pathetic human in my life. Finallytherock only had to poll 4 of us. And yes, between the 4 of us, we own more than your BTI holdings. The 4 of us own (combined) just over 1.2 million shares. Myself, I only own about 230k, (your buddy can verify as I sent him a screen shot of my BTI holdings a few months vack) so that should give ...more  
Comment by LOOPA441 on Feb 05, 2022 3:51pm
1) Sunshine 2) Lollipops 3) Rainbows https://www.youtube.com/watch?v=atY7ymXAcRQ&ab_channel=LesleyGore-Topic
Comment by chrispi on Feb 06, 2022 8:59pm
Finallytherock only had to poll 4 of us. And yes, between the 4 of us, we own more than your BTI holdings. The 4 of us own (combined) just over 1.2 million shares. Myself, I only own about 230k Fantastic! I'm truly happy that after such a long time of waiting you are going to make money on this investment :) Remember to save some for a rainy day, buy something nice for yourself, and give some ...more  
Comment by Finallytherock on Feb 05, 2022 10:14am
There's nothing going on. Nothing! You'll see
Comment by JDavenport on Feb 04, 2022 3:28pm
I guess, then, Finallytherock, yoiu're saying it's not quite yet finally the rock. Would you go find where I gave timelines, please? Rob Hutchison and ten deals by Christmas beat that out of me years and years ago. I think you're looking for the Eminent Imminent chrispi. But, just as chrispi can't predict imminent deals, nor can you predict no deals. My opinion is that deals are ...more  
Comment by Finallytherock on Feb 05, 2022 10:18am
There are no deals in the works. In a few months, we will be at the 2 year mark with Chiasi and not one update? That's not good. Prothena? Nothing in years. There is no interest in this platform. Otherwise they'd have something more substantial as far as a partnership or at least something in the clinic. Can you imagine working on the platform for something like 10 years and nothing in the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities